“A Switzerland-based startup called CRISPR Therapeutics just used gene-editing name to treat someone with the blood disease beta thalassemia.

That’s a big deal, because it marks the first time CRISPR gene editing has been used in a Western clinic — Chinese doctors have already tried using it to treat cancer — according to the MIT Technology Review.

“Treating the first patient in this study marks an important scientific and medical milestone,” CRISPR Therapeutics CEO Samarth Kulkarni said in a company-published press release, “and the beginning of our efforts to fully realize the promise of CRISPR/Cas9 therapies as a new class of potentially transformative medicines to treat serious diseases.”…”

Source: https://futurism.com/western-biotech-firm-treating-patient-crispr/